X
04Jun

Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing

As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By: Mintz - Consumer Product Safety Viewpoints
Source Url: https://www.jdsupra.com/legalnews/cannabis-derived-ingredients-in-fda-22118/

Related

A New Decade Begins! Ensure Your Business Is Up to Speed on California’s New Employer Requirements

The close of the decade ended with a flurry of activity on the labor and employment front, creating ...

Read More >

Can I Tell my Employee to Please Shut Up?

Sometimes the school teacher refrains, “everyone be quiet” or “back to your corners” can feel li...

Read More >

Benesch Market Intelligence: Health Care Quarterly Report - Q3 2019

Shepherd Premier Aims to Open 30 Small-Home Communities By 2022 - Aug 11th, 2019 via Senior Housin...

Read More >

Expansive Changes Coming to the New York State Human Rights Law

On June 19, 2019, the New York State Legislature passed Senate Bill S.6577, which upon Governor Cuom...

Read More >

Does Pennsylvania Recognize Strict Liability Claims Against Medical Device Manufacturers? A Pennsylvania federal court calls the question.

For at least two decades, Pennsylvania law has recognized an exemption from strict liability for pre...

Read More >

Tax Issues to Consider in Buying or Holding Distressed Debt

In times of economic tumult, many an entrepreneur’s fancy turns to thoughts of acquiring, and profi...

Read More >